DiFusion Technologies said it secured CE Mark approval in the European Union for its CleanFuze antimicrobial spine implant line.
Georgetown, Texas-based DiFusion said the CleanFuze devices are designed to reduce surgical site infections using its antimicrobial orthobiologic polymer.
Surgical site infections are the 4th-largest cause of death in the U.S., according to a press release.
“We are extremely gratified to announce European clearance of our CleanFuze line of antimicrobial spinal implants. This material has been in development for over 5 years and attaining this milestone represents significant value for our shareholders,” co-founder & CEO Derrick Johns said in prepared remarks.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.